Trial · NCT01701362
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Baseline Mean Pain Score | Baseline | Intent to Treat (ITT) population: all randomized participants who took at least one dose of study drug | units on a scale | MEAN |
| PRIMARY | Change From Baseline to Week 15 in Weekly Mean Pain Score | up to Week 15 | ITT population: all randomized participants who took at least one dose of study drug | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Patient Global Impression of Change (PGIC) at Week 15 | Week 15 | ITT population: all randomized participants who took at least one dose of study drug | Participants | NUMBER |
| SECONDARY | Change From Baseline in Overall Weekly Mean Sleep Interference Score (SIRS) | up to Week 15 | ITT population: all randomized participants who took at least one dose of study drug | units on a scale | MEAN |
| SECONDARY | Change From Baseline in Pain Severity Index (Brief Pain Inventory-short Form [BPI-sf]) | Week 15 | ITT population: all randomized participants who took at least one dose of study drug | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Pain Interference Index (BPI-sf) | Week 15 | ITT population: all randomized participants who took at least one dose of study drug | units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline to Endpoint in Quality of Life Using EuroQol (EQ-5D) Health State Profile Scores | Week 15 | ITT population: all randomized participants who took at least one dose of study drug | Units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Baseline Scores in the Medical Outcomes Study Sleep Scale (MOS-SS) - Sub-domain Score. | Baseline | ITT population: all randomized participants who took at least one dose of study drug. | Units on a scale | MEDIAN |
| SECONDARY | Mean Change From Baseline in the Medical Outcomes Study Sleep Scale (MOS-SS) - Sub-domain Score. | Week 15 | ITT population: all randomized participants who took at least one dose of study drug. | Units on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Participants in MOS-SS With Optimal Sleep Status. | Week 15 | ITT population: all randomized subjects who took at least one dose of study drug | Percentage of participants | NUMBER |
| SECONDARY | Percentage of Responders to Treatment With Pregabalin Measured as Reduction in Mean Pain Score of ≥30%. | Week 15 | ITT population: all randomized participants who took at least one dose of study drug | Percentage of participants | NUMBER |
| SECONDARY | Percentage of Responders to Treatment With Pregabalin Measured as Reduction in Mean Pain Score of ≥50% | Week 15 | ITT population: all randomized participants who took at least one dose of study drug | Percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01701362/outcomes